Records containing: Mild Alzheimer's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-16Modulation of Hippocampal Circuitry and Memory Function With Focused Ultrasound in Amnestic MCI
-
CLINICAL_TRIALS study record update · 2025-04-17A 24-month, Randomized-control, Double-blind, Multi-center, Delayed-start, Pilot Study Evaluating Thrombin Inhibitions Alzheimer's Disease Using 150mg Dabigatran Daily: A Novel Therapeutic Target for Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2025-04-08A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2024-07-03Deferiprone to Delay Dementia (The 3D Study): a Clinical Proof of Concept Study
-
CLINICAL_TRIALS study record update · 2024-05-13WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-20Lomecel-B Effects on Alzheimer's Disease: A Randomized, Double-Blinded, Placebo-Controlled Phase 2a Trial
-
CLINICAL_TRIALS study record update · 2023-12-06A Prospective, Randomized, Double-blind, Controlled Trial of rTMS in the Treatment of Mild Alzheimer's Disease Guided by Personalized Brain Functional Sectors(pBFS)
-
CLINICAL_TRIALS study record update · 2023-09-28Prospective Study on Anti-Amyloid-β Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Coverage of Evidence Development (The Anti-Aβ mAb CED Study)
-
CLINICAL_TRIALS study record update · 2016-12-05A Phase IIa Safety and Tolerability Study to Investigate the Effect on Sleep of 3 Doses of AZD5213 and Placebo in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment During 4 Weeks of Treatment, Placebo-Controlled
-
CLINICAL_TRIALS study record update · 2016-07-14Computer-based Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment (MCI) and Mild Alzheimer's Disease (AD)
-
CLINICAL_TRIALS study record update · 2016-04-19A 4-week, Parallel-group, Randomized, Double-blind, Placebo-controlled, Adaptive Proof of Concept Study of AQW051 at up to Three Dose Levels for the Treatment of Patients With Findings Consistent With Mild Alzheimer's Disease (AD) or Amnestic Mild Cognitive Impairment (Amnestic MCI)
-
CLINICAL_TRIALS study record update · 2012-08-30A Double-blind, Randomized, Placebo-controlled, Phase I , Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally-administered HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2011-09-07Early Detection of Mild Cognitive Impairment in Individual Patients
-
CLINICAL_TRIALS study record update · 2011-03-15A Double-Blind, Randomized, Placebo-Controlled, Multiple, Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2010-07-07Phase IV Study Safety & Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients.